In the past few years, the mechanisms that integrate the Ras-RAF-MEK-ERK pathway into the bladder cancer phenotypes have started to accumulate, including a subset of bladder tumors with focal amplifications of RAF1 gene, and found that these amplifications drive activation of the canonical MAPK pathway (14). The gene discussed is MAP2K7; the disease is urinary bladder carcinoma.